SCHEMBL7414052

SCHEMBL7414052

CCC(O)C(C)=Cc1ccc(OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
MAPT P10636 3/20 0.49
KDM4E B2RXH2 3/20 0.49
HPGD P15428 2/20 0.49
CYP3A4 P08684 3/20 0.46
TSHR P16473 2/20 0.46
CYP1A2 P05177 1/20 0.46
NFKB1 P19838 1/20 0.46
APEX1 P27695 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CYP2C9 P11712 1/20 0.45
ALOX15 P16050 1/20 0.45
CYP2C19 P33261 1/20 0.45
TAS1R3 Q7RTX0 2/20 0.43
TAS1R1 Q7RTX1 2/20 0.43
TUBB1 Q9H4B7 1/20 0.43
CYP2A6 P11509 1/20 0.41
GSK3B P49841 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7414050 1.00 ALDH1A1 (0.49) ALDH1A1MAPTKDM4EHPGDCYP3A4
SCHEMBL7411009 0.85 NPC1 (0.50) ALDH1A1MAPTKDM4ETSHRCYP1A2
SCHEMBL7411010 0.85 NPC1 (0.50) ALDH1A1MAPTKDM4ETSHRCYP1A2
SCHEMBL13306593 0.83 F3 (0.49) ALDH1A1MAPTKDM4EHPGDCYP3A4
SCHEMBL7091574 0.82 ALDH1A1 (0.55) ALDH1A1MAPTKDM4EHPGDCYP3A4
SCHEMBL24225567 0.78 ALDH1A1 (0.55) ALDH1A1MAPTKDM4EHPGDCYP3A4
SCHEMBL867263 0.78 ALDH1A1 (0.44) ALDH1A1TSHRLMNA
SCHEMBL4109907 0.78 ALDH1A1 (0.44) ALDH1A1TSHRLMNA
SCHEMBL4109909 0.78 ALDH1A1 (0.44) ALDH1A1TSHRLMNA
SCHEMBL867262 0.78 ALDH1A1 (0.44) ALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6482824-B1 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists ELI LILLY AND COMPANY 2002-11-19 US disclosed
EP-1124806-A2 USE OF N-SUBSTITUTED (3,6-DIHYDRO)-2H-1,2-OXAZINE DERIVATIVES AS SELECTIVE MGLUR1 ANTAGONISTS ELI LILLY AND COMPANY LIMITED (GB) 2001-08-22 EP disclosed
WO-2000026198-A1 N-SUBSTITUTED (3,6-DIHYDRO)-2H-1,2-OXAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE MGLUR1 ANTAGONISTS ELI LILLY AND COMPANY LIMITED (GB) 2000-05-11 WO disclosed
WO-2000026199-A2 USE OF N-SUBSTITUTED (3,6-DIHYDRO)-2H-1,2-OXAZINE DERIVATIVES AS SELECTIVE MGLUR1 ANTAGONISTS ELI LILLY AND COMPANY LIMITED (GB) 2000-05-11 WO disclosed